Skip to main content
    S

    Solid Biosciences LLC (SLDB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $6.48
    -0.36 (-5.26%)

    Market Cap: $763.42M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Solid Biosciences LLC (SLDB) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Solid Biosciences LLC are Sana Biotechnology (SANA), Syndax Pharmaceuticals (SNDX) and DBV Technologies (DBVT). By market cap, Solid Biosciences LLC ranks 4th of the 13 companies on this page; Jade Biosciences (JBIO) is the largest at $1.03B.

    Peer Comparison

    SLDB's revenue growth of -100.0% is below the peer median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Solid Biosciences LLC (SLDB)$763.42MN/AN/A0.0%N/A-100.0%0.00%
    Sana Biotechnology Inc (SANA)$605.26MN/AN/A0.0%-46.8%0.0%0.00%
    Syndax Pharmaceuticals Inc (SNDX)$850.77MN/A2.8x-72.3%-65.0%81.6%0.00%
    DBV Technologies (DBVT)$692.19MN/AN/A0.0%-130.3%-42.9%0.00%
    Sagimet Biosciences Inc. Series A Common Stock (SGMT)$735.18MN/AN/A0.0%N/A0.0%0.00%
    Orchestra BioMed Holdings Inc. (OBIO)$570.61MN/A14.7x-182.5%-97.0%-89.4%0.00%
    Jade Biosciences, Inc. (JBIO)$1.03BN/AN/A0.0%N/A0.0%0.00%
    Climb Bio Inc (CLYM)$608.53MN/AN/A0.0%N/A0.0%0.00%
    Design Therapeutics Inc (DSGN)$670.46MN/AN/A0.0%N/A0.0%0.00%
    4D Molecular Therapeutics Inc (FDMT)$689.52MN/A8.5x-208.6%-46.4%4506.0%0.00%
    DiaMedica Therapeutics Inc (DMAC)$474.29MN/AN/A0.0%N/A0.0%0.00%
    Immix Biopharma Inc (IMMX)$657.09MN/AN/A0.0%-14.9%0.0%0.00%
    Prime Medicine, Inc. Common Stock (PRME)$949.85MN/A105.5x0.0%N/A243.9%0.00%
    Peer median$679.99MN/A11.6x0.0%-55.9%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Solid Biosciences LLC, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Sana Biotechnology Inc (SANA)
    Sana Biotechnology, Inc., a biotechnology company, focuses on the use of modified cells as medicines. The company is headquartered in Seattle, Washington.
    SANA competitors
    Syndax Pharmaceuticals Inc (SNDX)
    Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer.
    SNDX competitors
    DBV Technologies (DBVT)
    DBV Technologies SA, a clinical-stage biopharmaceutical company, is dedicated to the research and development of epicutaneous immunotherapy products.
    DBVT competitors
    Sagimet Biosciences Inc. Series A Common Stock (SGMT)
    Sagimet Biosciences Inc. (SGMT) is an innovative biotechnology company focused on developing breakthrough treatments for metabolic diseases...
    SGMT competitors
    Orchestra BioMed Holdings Inc. (OBIO)
    Orchestra BioMed Holdings, Inc. is a therapeutic device company that develops therapeutic treatments and products for cardiovascular diseases.
    OBIO competitors
    Jade Biosciences, Inc. (JBIO)
    Jade Biosciences, Inc. is a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune...
    JBIO competitors
    Climb Bio Inc (CLYM)
    Climb Bio, Inc., a biotechnology company, focuses on developing therapies for autoimmune-driven inflammatory diseases.
    CLYM competitors
    Design Therapeutics Inc (DSGN)
    Design Therapeutics, Inc. develops therapies for the treatment of degenerative disorders caused by nucleotide repeat expansions.
    DSGN competitors
    4D Molecular Therapeutics Inc (FDMT)
    4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops candidate products using its adeno-associated virus vectors.
    FDMT competitors
    DiaMedica Therapeutics Inc (DMAC)
    DiaMedica Therapeutics Inc., a clinical-stage biopharmaceutical company, develops treatments for neurological and kidney diseases.
    DMAC competitors
    Immix Biopharma Inc (IMMX)
    Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, is dedicated to the development of various tissue-specific therapies in oncology...
    IMMX competitors
    Prime Medicine, Inc. Common Stock (PRME)
    Prime Medicine, Inc. is a pioneering biotechnology company specializing in genetic medicine through its proprietary Prime Editing technology...
    PRME competitors

    Frequently Asked Questions About SLDB

    Who are Solid Biosciences LLC's main competitors?

    The companies most similar to Solid Biosciences LLC include Sana Biotechnology (SANA), Syndax Pharmaceuticals (SNDX), DBV Technologies (DBVT), Sagimet Biosciences Inc. Series A Common Stock (SGMT) and Orchestra BioMed Holdings (OBIO), listed from the closest match.

    Who is Solid Biosciences LLC's biggest competitor?

    Jade Biosciences (JBIO) is the largest of the similar companies at $1.03B; Sana Biotechnology (SANA) is the closest match by business profile, size, sector and industry.

    How does SLDB stock compare with its competitors?

    SLDB's net margin is 0.0% against a peer median of 0.0%.

    Which of Solid Biosciences LLC's competitors pays a higher dividend?

    Solid Biosciences LLC pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Solid Biosciences LLC bigger than its competitors?

    No. Solid Biosciences LLC is 4th by market cap among the 13 companies on this page; the largest is Jade Biosciences (JBIO) at $1.03B.